Confirm
Skip to main content Skip to notification content
Back

Are you looking for:

Products
Products
Event promotions
Event promotions
Event promotions
Make a payment
Make a payment
File a claim
File a claim
Frequently asked questions
Frequently asked questions
Error Image

banner

Manulife Connect Cambodian Customer to Award-Winning Multi-Cancer Screening in Singapore

Manulife is providing customers with access to the Multi-Cancer Detection (MCD) test* as part of its focus on longevity through a partnership with Guardant Health, a global leader in blood-based cancer testing with over a decade of experience¹. This exclusive partnership marks the first introduction of the Guardant Health MCD test* in Asia and empowers customers with earlier cancer detection capabilities.

 

What is Multi-Cancer Detection (MCD)* test by Guardant Health?

For more information

The Guardant Health MCD Test*

is intended to detect 10 cancers – bladder, breast, colorectal, esophageal, stomach, liver, lung, ovarian, pancreatic and prostate cancer through a single blood draw. 

The MCD Test* by Guardant Health is:
  • Scientifically proven, with technology backed by over 1 million oncology blood samples tested
  • Innovative - Guradant Health's MCD test has received US FDA breakthrough device designation's
<p>For more information on the MCD test* offered by Guardant Health</p>

For more information on the MCD test* offered by Guardant Health

For more information on the MCD test* offered by Guardant Health
<p>Frequently - Ask - Questions</p>

Frequently - Ask - Questions

Frequently - Ask - Questions
<p>Terms &amp; Conditions</p>

Terms & Conditions

Terms & Conditions
Sources:
  1. The US FDA Breakthrough Device designation referenced includes eight cancer types—bladder, colorectal, oesophageal, gastric, liver, lung, ovarian, and pancreatic cancer. Source: Guardant Health. FDA Grants Breakthrough Device Designation to  Guardant Health’s Multi-Cancer Detection (MCD) Test. Published June 3, 2025.
  2. Data on file. Guardant Health, Inc. Sep, 2025.

Here’s how you can access the Multi-Cancer Detection (MCD)* test:

•   Speak with a Manulife Insurance Advisor on your financial needs *Fill lead form below*

•   Purchase a suitable plan

•   Eligible customers will receive a lucky draw ticket for a chance to win a complimentary Multi-Cancer Detection (MCD) test worth up to USD 1,500. 

    • We need to collect your personal information in order to respond to your inquiry. 

  • I have read and agreed Term of Use and Privacy Policy

    • This is a required field
    • Thank you

     

    Thank you for submission!

    You can fine the Oversea Health Concierge Booklet file below:

     

    Review

    Oops!
    Error 404
    Please excuse us

    Sorry. We are processing a few things behind the scene. Please try again in a few moments.

    Return to Home

    But wait, here are some links we think might interest you:

    Learn about us

    Check out our careers

    See what's happening with us

    Looking for helps

    Terms and conditions:

    • Lucky draw entries are allocated based on the applicable premium tier.
    • Prizes are non-transferable and cannot be exchanged for cash or substituted with any other items.
    • The prize will be forfeited if the customer cancels or terminates the policy during the waiting period.
    • The prize is valid for one (1) year from the date of award.
    • The prize does not include flights, transportation, or any related travel expenses.
    • Manulife reserves the right to amend these terms and conditions at any time without prior notice.

    About Us

    Product

    Services

    Careers with Us

    Term of Use        Privacy Policy

    ©2019 Manulife (Cambodia) PLC.

    The Manufacturers Life Insurance Company and its subsidiaries.

    All rights reserved.